Notice of Results

RNS Number : 9010Q

Instem plc

05 September 2014

 



05 September 2014

Instem plc

Notice of Results

Instem plc (AIM: INS.L), a leading provider of IT solutions to the global early development healthcare market, will be announcing its unaudited interim results for the six months ended 30 June 2014 on Wednesday 24^th September.

Management will be hosting a presentation for analysts on the day of results at 09:30am at the offices of N+1 Singer, One Bartholomew Lane, London, EC2N 2AX.

If you wish to attend, or require further information, please contact Bob Huxford or Sam Allen at Walbrook PR on 020 7933 8780 or email [e-mail] to register.

For further information, please contact:

Instem plc	www.instem.com
Phil Reason, CEO	Tel: [phone]
Nigel Goldsmith, CFO
N+1 Singer (Nominated Adviser & Broker)	Tel: [phone]
Richard Lindley
Nick Owen
Walbrook PR Ltd	Tel: [phone] or [e-mail]
Bob Huxford	Mob: [phone]
Sam Allen	Mob: [phone]

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum.  Instem applications are used by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.

Instem's established portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan. 

 

END

 

 

NORFMGGLKDKGDZM